Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

Clinical trial NCT02988401 · COMPLETED

Trial details

NCT number: NCT02988401
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive

Start date: 2017-12-01
Primary completion: 2021-12-17
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.